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Abstract 
This paper presents a predictive accuracy com- 
parison between the Multivariate Logistic Re- 
gression (MLR) and the Bayesian Neural Net- 
work (BNN). The lat,ter is presented in this pa- 
per as an alternative to the MLR (MLR). The 
M LR and BNN have been used to  ident,ify early 
breast cancer patients wit,h high risk of tumour 
recurrence at the time of initial resection. 
1 Introduction 
Several issues have been raised by stat,isticians 
and medical personnel in relation to the appli- 
cation of the standard Multilayer Perceptron to 
the analyss of medical data. The problem lies in 
the application of the Artificial Neural Net,worlts 
issues such as the which input. 
ant ancl t,he correct, number of 
layers ancl the nnmber of units in each layer in 
order to obtain a certain level of performance. 
To resolve the problem of select,ing t,he op- 
timum design choices for t.he MLP! we applied 
Bayes' Theorem: which embodies the philosophy 
of William Occam, to provide a framework for 
selecting the optimum ANN architecture. The 
archit,ect,ure i s  opt,imal in the sense that prefer- 
ence is given to  the simplest* model (least, num- 
ber of layers and units) which adequately mod- 
els the training data. Model comparison can he 
done by evaluating a quantitative value t,ermed 
the evidence. The evidence calcolated for each 
ANN model t,alies into consideration the good- 
ness of fit and the complexity of the model. The 
principle penalises complex models and favours 
"l'his research was supporbed by lhe Caricsr f'ounda- 
t ion uC Weslerri Australia. 
the simplest model. Using the Bayesian Neural 
Network (BNN), we were able to address some 
of the drawbacks of t8he standard MLP. 
Bayesian methods for induct,ive inference were 
developed in det,ail by a Cambridge geophysi- 
cist., Sir Harold Jefferys [5]. Bayes' theorem is 
regarded as n form of common sense reasoning, 
providing the framework to manipulate proba- 
bility distributions. But, t,o apply Bayesian rea- 
soning, firstly we need to transform the medi- 
cal information into a numerical probability dis- 
tribution using some other principle. This can 
be achieved using the standard statistical mod- 
els such as the Multivariate Logistic Regression 
(MLR) or ANNs. Bayes' framework can also be 
used to determine the significance of each indi- 
vidual risk factor to the outcome. The frame- 
work, t,ermed Azrtomcitzr Relevuace Determncr- 
tion (ARD), is due to published works of MacKay 
in lY9l - 1992 [6, 7, 81: Gull [3;  41. 
About 7000 Australian womens are diagnosed 
with early breast cancer annually [2]. In many 
of these patients! breast cancer is a systemic dis- 
ease at diagnosis and is therefore not curable hy 
surgical removal of t,he primary t,nmour alone. 
Breast cancer i s  a heterogeneous disease; resnlt- 
ing in a wide range of treat,ment options. These 
treatments vary widely in toxicit,y, from rela- 
tively harmless (such as hmoxifen) to  highly 
aggressive experimental therapy (such as bone 
narrow transplantation). Decisions about which 
patients to t,reat with these different, forins of 
adjuvant, therapies require that. we confront, two 
important issues. Firstly, what i s  an accept,ahle 
risk of recurrence, that, is; a risk so low as to ar- 
gue against the need for systemic therapy. iiccu- 
rate assessment of t,he probability of recurrence 
i s  therefore essential in deciding the appropri- 
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ate adjuvant treatment for individual patients 
[I]. Secondly, the question arises as to whether 
we have the prognostic factors to predict. the risk 
of reciirrenre with a high degree of accuracy. 
This paper focuses on the question of how we 
can best identify node positive patients who will 
have a high or low probability of recurrence at 
t.he early stage of the disease. We invest,igated 
the use of four risk factors previously analysed 
using statistical methods by Seshadri and asso- 
ciates [9] to predict the risk of reciirrence for 
individual patients following the removal of the 
priina.ry t,umour and initial adjuvant, therapy. 
Risk prediction allows identification of patients 
to be considered for addit.iona1 therapy or to se- 
lect appropriat,e treatment. Patients expected 
to have low risk of recurrence will be spared from 
additional or delayed toxic effects 
2 The Bayesian Neural Net- 
work Forinalism 
David MacKay [b: 7: 81 has provided a com- 
prehensive and detailed description and analy- 
sis of the incorporation of the Bayesian inference 
and evidence framework with the MLP network. 
The BNN has been implemented by MacKay [6] 
osiiig a. deterministic met.hud invulviiig Gaiis- 
sian approximation. 
The formulation of the BNN involves solving 
an iterative top-domn approach for four levels of 
inference as shown in Figure 1 [6]. 
Specify network design choices 
(1) Numbelof layers, 
(11) Numberot units per layer. 
The Four Levels of Inference 
(IO Regularizer Parameter 
set of risk factors. The accuracy of the pre- 
diction will be dependent on the model con- 
structed. Therefore, only the simplest model 
that, best describes the training dala should be 
used for Level IV inference. Level I11 of the in- 
ference process involves comparing and ranking 
preferences for alternative ANN models using 
the evidence framework, P ( D  I . M i ) .  The evi- 
dence from each trained ANN model can only be 
determined if we have inferred the most, proba- 
ble weight ( w ~ p ) ,  regulariser ( a )  and noise scale 
parameters (p) determined from inference level I 
and 11. The following sections will describe each 
level of inference in detail. 
2.1 Bayesian Iiifereiice of the weight 
parameters (Level I) 
Bayesian analysis involves using the out,put of 
the network, g(x) t*o construct, the likelihood 
function! P ( y  I xlw) for t,he training data D = 
(x!y). We wwit to train t,he BNN netmork to 
give ns the most probahle weight parameter, 
w,lfpi given the data (x; y) :  network configura- 
tion ( M i )  and some scaling parameters which 
will be discussed lat,er in t,his chapter. Using 
Bayes' rule, the posterior probability of the weight 
parameter is; 
P('D 1 w , M , )  P ( w  I D,Mt)  = P ( w  I D,ML) P(D 1 M , )  
i 1) 
where P(w I %,Mi) is the post,erior probability 
of the ANN weight parameters, w .  
Infering the most. probable weight,s involves: 
1. Computing the likelihood, P ( y  1 x,w, Mi) 
of the data. 
2. Computing t.he prior probability ofthe weight 
paramet,ers; P ( w  I %, .Mi) 
LeYd I1 lnierence 
and n o m  scalmg ( p  J paramefeis plus lher variances 
, lnferfhemosiprobable weigh1 regukmei (a) 2.1.1 Computing the likelihood, P(z, I 
and variances 
w , M , )  
e ANN training procedure is used to find a 
of weights that maxiiniSes the likelihood of 
Calculate evidence e training data, D 
A4aZ n i o z  Ad Figure I: Four levels of BNN inference w p ( ~  I .M;) =w E w p(o, 1 M ; )  
3=1 
The ultiinak goal in the modelling process is ( 3 )  
to be able to  predict the outcome for iiew pa- 
tients based on the information cont,ained in a 
The MLP network is usually trainer1 to  best fit 
the tmining dat,a, D by minimising a quadratic 
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error function or the Euclidean normi 
The funct,ional form of t,he liltelihoocl model 
can be reduced to a Gaussian distribution. 
where 19 = 5 is t,he noise level and ZD(/?) = 
ar M / 2  
p ’ 
IVlacKay [6, 71 proposed the use of a “weight- 
decay” or wgrrlnl-ising tt.riir ( CY)  to prevent, weights 
of irrelevant, nnits from growing too large. The 
regulariser term forms the smoothing parameter 
of the ANN model. Inclusion of the regulariser 
term penalises large weight,s in the t,raiiiing pro- 
Training the ANN network to maximise the 
lilwlihood of the training d a h  can also he viewed 




where I‘(P I N ;  8, .,U;) is t,lie norsnalisat,ioii coil- 
stant and o is the regularising term. 
2.1.2 
The oiily consistent, prior for t,he weight param- 
etmer, w is of t,he Gaussian form: 
Prior probability of the wcights 
where Z<,(YY) = I mp(-nE~v)&d  and Ew = 
Substitut,ing equations (5) and (7) into equa- 
i X W 2 .  




where ~ g ( a ,  a) = J ea~+-[PEn + ~ E I ~ ] ) C P ~  
and t,raining t,he ANN by minimising the objec- 
t.ive function, cI)(u) = ,5’En + N E W ,  would infer 
Qhe most probable weight,. w , l ~ p .  
2.2 Selecting the optiiiial regulariser 
Solving the objective function, @(U)  involves de- 
termining the values of the regulariser term N 
and the noise level p. The optimal N and ,3 
term can be found by differentiating, logP(y  I 
x, a ,  /?; M i )  with respect t.o Q and /? and setting 
these equations to zero. 
value, (Y (Level 11) 
2.3 Evaluating the evidence (Level 
Level I11 inference involves selecting the ANN 
model with the highest recorded evidence, P(lD I 
M i ) .  The posterior distribution encapsulates all 
the information about M ,  given the informatmion 
of the training data, %. Therefore, the evidence 
for the model. M i ,  is: 
P(y 1 x, M i )  = 1 P ( y  I x. a ,  p, .,Ui)P(n.: 19 I M i ) d ~ @  
111) 
(10) 
3 Breast Cancer Prognosis 
The data set used in this investigat,ion relates t80 
351 women in South Aust,ralia and Western A u s -  
tralia diagnosed with breast carcinoma between 
1987 and 1992. For all pat,ients, t,heir diagno- 
sis was confirmed by biopsy and treated either 
by total (75% of patient.s) or partncd (26% of pa- 
t,ient#s) mastectomy. All pat,ient,s had had axil- 
lary lymph node clearance wit8h posit,ive confir- 
mation of met,astases therein. The four criteria 
for inclusion in t,his st,udy are: 
Only node posit,ive pat,ients are considered. 
Patients wit,h stage-IV disease or for whom 
axillary clearance was not performed were 
excluded. 
Patients without, recurrence are required 
t,o have a niinimi.iiii follow-up period of 18 
months. 
Information on all t,he risk factors consid- 
ered is available. 
This study concentrat,es only on t,he significant, 
predictive property of risk factors to predict lo- 
cal or distant recurrence for the node positive 
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patient within eighteen mont,hs after diagnosis. We have noted in t,he earlier sect,ions t,hat the 
A consecutive series of 351 node-positive pa- BNN network is an integration of the Multilayer 
tients with complet,e axillary dissection were avail- Perceptron and Bayes Theorem. Using t,he BNN 
able for this case st,udy. Detailed descriptions 
regarding the preparation of breast sample for 
hormone receptor and Cat.hepsin-D amlysis have 
been given in [9]. 
3.1 Risk Factors 
Hist,opathological features considered in this case 
study are similar to the study conduct,ed by Se- 
shadri [9].In this study, apart from analysing the 
prognostic values of the respective risk factors, 
considera.tion was also given to predict,ing the 
risk of relapse for individual patient,% The risk 
fa.ctors used in the study are Tumour Size (TS)! 
Niiinber of Nodes, Estrogen Receptor (ER) and 
Cat!hepsin-D (Cath-D). 
The breast carcinoma data were analysed 11s- 
ing both the Bayesian Neural Network (BNN) 
and the Multivariate Logist.ic Regression (h4LR) 
methods. Patients were assigned randoinly ancl 
independently from the dat,a set to a t,raining 
set used to construct. t,he model and a t,esting set, 
used lo  evaluate the performance of the model. 
h randoin sample of 184 patients (150 MET- 
and 34 MET+) was selected t,o provide the train- 
ing data., leaving 167 patientas (137 MET- and 30 
MET+) as a test set on which to validate the 
predict,ions. 
4 Results 
4.1 Coiistructioii of the Standard 
network, we can use t,he Occam framework to 
determine the evidence for each ANN network. 
The evidence framework allows 11s to rank pref- 
erences for alternative BNN models. Several 
BNN networks with different numbers of hid- 
den units were trained and the log evidence, 
P ( D  I of each trained BNN model was 
evaluated. The evidence for each BNN model 
trained is shown in Figure 2. Since the training 
process of the BNN network involves initialising 
Since the training process of t,he BNN net- 
work involves initialising the weight parameters 
and the regulariser terms to small random val- 
ues! we decided t.o retra.in the BNN network 
three times for each design choice to the same 
tolerance level and evaluate the evidence each 
time. The results tabulated in Figure 2 show 
a rapid increase of P ( y  I x , M ; )  with increas- 
ing numbers of hidden units. Additional hidden 
units improve the fit but also increases the com- 
plexity of the model. The BNN incorporating 
the Occam Razor selected the optimum BNN 
model to best fit the data, with oiily 9 hidden 
units. Therefore the BNN architecture used for 
the classifica,tion analyses mill have the follow- 
ing architecture, 4 input, units; 1 hidden layer 
with 9 units and 1 outpiit unit. 
MLR, Bayesian MLR and BNN 
inodel 
For the const,ruction of the Standa.rd 1\KR mod- 
els; the standard multivariat,e logistic regression 
method was applied. The Bayesian h4LR model 
was constructed using the BNN net.work with 
no hidden nodes a.ncl one output node with sig- 
moidal activa.tion function. 'This BNN network 
was trained to  maximise the likelihood of the 
t,raining data. This is similar in principle t,o 
t,he multivariate 1ogist.ic finiction, except, in t.his 
case, regulariser terms are attached to each in- 
put. The parametric function of t,his BNN model 
is equivalent to t,he standard h4LR model. 
In the case of the BNN modeli one hidden 
layer was used in the modelling process. The 
sigmoidal ahvat ion  fiinct,ion was applied to all 
t8he units wit,h the exception of the input, units. 
hl.Ulilillliitlili" ,,,,. 
Figure 2: Relationship bet.ween the number of 
nodes and log of the evidence, P ( y  I x; M i )  
In the multivariate analysis, the results from 
both tshe MLR and BNN model tabulated in Ta- 
ble 1 show that, only the pathologic status of the 
lymph nodes a.nd the ER concentration were sta- 
tistically significant in the multivariate model. 
In the MLR model, both these risk factors have 
P < 0.05 and in the BNN model, the regulariser 
term or the decay term associated wit,h each iii- 
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R,isk Fact,ors Bayew&$9 hidden units was selected. The BNN net- 
1. Tumour Sze 0.3&rk with 9 hidden units achieved t,he highest, 
2. No of Nodes Involved 0.02u 0.04l)idence as shown in Figure 2. We can now 
3. Estrogen Receptor 0.0&6 away with the ad-hoc method of selecting 
4. Cathepsin-D 0.884 0.3MJLP models. Apart from providing t,he evi- 
dence framework for ranking A4NN models. we 




Table 1: Significance of Risk Factors 
- 
Testing Predicted 
Actual M- M+ M- M+ M- M+ 
M- 79 58 80 67 84 53 
M+ 10 20 8 22 9 31 
Tot,al 89 78 88 79 !13 74 
Data Stcl MLR Bagcs MLR BNN 
- 
- 
Table 2: Comparison of the classification accii- 
racy 
put is small in comparison to the a values for 
tmnonr size and Cathepsiii-D (larger by a factor 
of 10). Note that in both the MLR and BNN 
analyses, risk factors which are uncorrelated to 
the. outcome will he inferred large P and a val- 
ue:;. 
4.2 Forced Classification Accuracy 
Patient,s were stratified into two risk groups, 
M-+ and M-. Table 2 tabulates t.he predicted 
status of individual pat,ients. 'The BNN has higher 
predictive accuracy for both NI+ and M- pa- 
tients in comparison to the MLR and t,he Bayesian 
MILR model. 
5 Discussion 
The analyses carried out, in this case st,udy con- 
centmtes on two things. Firstaly, can we pre- 
dict t.he probability of recurrence for t,he node- 
posit,ive patient on the basis of information about 
tumour characteristics. Srcondly, to compare 
t,he predictive accuracy of t,he MLR and BNN 
network since the use of tlie BNN net,work is a 
novel approach in this area. The MLR) Bayesian 
MILR and BNN models were const,ruct,ed using 
184 patients (training dat,a) and the remaining 
167 patients were used tso assess their predictive 
quality. 
The BNN embodies t,he Occam principle and 
Bayes Theorem to provide a qnaiit,it8at,ive as- 
sessment for ranking alternat,ive ANN models. 
lrsing t,he evidence framework. a BNN network 
- 
can also determine which risk factors are cor- 
relat,ed to the prediction of recurrence. This 
knowledge has previously been embedded in the 
distributed weights of the bILP model. TJsing a 
regulariser term ( a )  for each input., the N asso- 
ciated with irrelevant inputs will be given large 
values to  prevent these inpiits from affect,ing the 
resulting predict,ion. In the multinomial model: 
only two variables were found to be st,at,istsi- 
cally significant independent predictors. They 
are number of nodes involved (N = 0.029) and 
the ER concentration ( a  = 0.016). The same 
two variables were also found to  be stlatist8ically 
significant in the MLR model, P = 0.02 and 
P = 0,007, respectively. Both the BNN and 
the MLR models found the risk fact,ors tumour 
size and Cathepsin-D to be uncorrelated to pre- 
diction of recurrence. Note that t,he prognost,ic 
significance of ER may be due t,o its relation- 
ship with response t,o tamoxifen administered 
to some patients. 
he MLR and the BNN models were also t,ested 
on 167 patient,s not iised t.o construct the model 
to assess their predict,ive quality. The BNN net,- 
work predictbed more accurately for bot,h MET+ 
patient,s (70.0%) and the MET- pat,ients (61.3%). 
In comparison: the MLR predictmion accuracy 
was 57.6% and 66.7% for MET- and MET+ re- 
spectively. The higher percentage of patients 
correctly classified as having MET+ indicates 
t,hat t8he adjuvant t,herapy selected for individ- 
ual patients only prolongs the disease free recur- 
rence for 38.7% of the MET- patients. The anal- 
ysis carried out considered only four risk fact.ors 
to predict the prohahilit-y of relapse and was re- 
stricted to patients who had had some form of 
ad.jnvant therapy. 
In view of the small sample size! further veri- 
fication of the BNN model is required before it 
can he applied t,o assess the probability of re- 
currence in larger populat,ions. 
6 Conclusion 
The novel analysis using the Bayesian Neural 
Network has been shown t.o eliniinate soine of 
the drawbacks of the standard MLP ndwork. 
The evidence framework and t,he aut.omatic rel- 
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evance determination provide ways t,o determine 
the optimum network size plus ident,ifying in- 
puts which are independeiit, predictors of the 
outcome. The BNN model mas more acc1irat.e 
(higher liltelihood) and achieved higher predic- 
t,ive, value in compa.rison to the multivariate lo- 
gistic regression models. This case st,udy con- 
centratmecl on assessing the risk of recurrence for 
node positive patients for Tvhom some form of 
adjuvant therapy has been given. The same 
modelling procedure can he used to assess the 
risk of recurrence for node negative pat.ients or 
for iiode positive pat.ient.s for whom acljuvant, 
therapy have not. been administ,ered. This mod- 
elling process will enable clinicians to assess the 
risk of recurrence given the information about, 
tumour characterist,ics and t.0 select. appropri- 
a.te treat.ment for both high risk node negative 
pat,ients and node positive patienk. 
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